Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayesha N Shajahan

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
International Journal of Molecular Sciences|November 27, 2021
Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast CancerErin R Scheidemann, Ayesha N Shajahan-Haq
Expert Review of Anticancer Therapy|September 16, 2011
Autophagy and endocrine resistance in breast cancerKatherine L Cook, Ayesha N Shajahan, Robert Clarke
Journal of Cellular and Molecular Medicine|January 22, 2008
Tyrosine phosphorylation-dependence of caveolae-mediated endocytosisMaria Sverdlov, Ayesha N Shajahan, Richard D Minshall
Drug News & Perspectives|July 18, 2009
The role of X-box binding protein-1 in tumorigenicityAyesha N Shajahan, Rebecca B Riggins, Robert Clarke
Pharmacology & Therapeutics|June 23, 2018
CDK4/6 inhibitors in breast cancer therapy: Current practice and future opportunitiesFilipa Lynce, Ayesha N Shajahan-Haq, Sandra M Swain
Methods in Molecular Biology (Clifton, N.J.)|April 19, 2023
Mathematically Modeling the Effect of Endocrine and Cdk4/6 Inhibitor Therapies on Breast Cancer CellsWei He, Ayesha N Shajahan-Haq, William T Baumann
Metabolites|February 19, 2015
Application of metabolomics in drug resistant breast cancer researchAyesha N Shajahan-Haq, Mehar S Cheema, Robert Clarke
Biomolecules|July 12, 2017
MYC-Driven Pathways in Breast Cancer SubtypesYassi Fallah, Janetta Brundage, Paul Allegakoen, et al.
Iscience|May 26, 2023
Modeling breast cancer proliferation, drug synergies, and alternating therapiesWei He, Diane M Demas, Ayesha N Shajahan-Haq, et al.
Plos One|January 12, 2010
Co-inhibition of BCL-W and BCL2 restores antiestrogen sensitivity through BECN1 and promotes an autophagy-associated necrosisAnatasha C Crawford, Rebecca B Riggins, Ayesha N Shajahan, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|November 27, 2021
Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast CancerErin R Scheidemann, Ayesha N Shajahan-Haq
Expert Review of Anticancer Therapy|September 16, 2011
Autophagy and endocrine resistance in breast cancerKatherine L Cook, Ayesha N Shajahan, Robert Clarke
Journal of Cellular and Molecular Medicine|January 22, 2008
Tyrosine phosphorylation-dependence of caveolae-mediated endocytosisMaria Sverdlov, Ayesha N Shajahan, Richard D Minshall
Drug News & Perspectives|July 18, 2009
The role of X-box binding protein-1 in tumorigenicityAyesha N Shajahan, Rebecca B Riggins, Robert Clarke
Pharmacology & Therapeutics|June 23, 2018
CDK4/6 inhibitors in breast cancer therapy: Current practice and future opportunitiesFilipa Lynce, Ayesha N Shajahan-Haq, Sandra M Swain
Methods in Molecular Biology (Clifton, N.J.)|April 19, 2023
Mathematically Modeling the Effect of Endocrine and Cdk4/6 Inhibitor Therapies on Breast Cancer CellsWei He, Ayesha N Shajahan-Haq, William T Baumann
Metabolites|February 19, 2015
Application of metabolomics in drug resistant breast cancer researchAyesha N Shajahan-Haq, Mehar S Cheema, Robert Clarke
Biomolecules|July 12, 2017
MYC-Driven Pathways in Breast Cancer SubtypesYassi Fallah, Janetta Brundage, Paul Allegakoen, et al.
Iscience|May 26, 2023
Modeling breast cancer proliferation, drug synergies, and alternating therapiesWei He, Diane M Demas, Ayesha N Shajahan-Haq, et al.
Plos One|January 12, 2010
Co-inhibition of BCL-W and BCL2 restores antiestrogen sensitivity through BECN1 and promotes an autophagy-associated necrosisAnatasha C Crawford, Rebecca B Riggins, Ayesha N Shajahan, et al.
Pageof 6